Stocks and Investing Stocks and Investing
Tue, January 10, 2023
Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023

Drew Ranieri Maintained (AVNS) at Sell with Increased Target to $26 on, Jan 6th, 2023


Published on 2024-10-28 00:47:27 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Increased Target from $24 to $26 on, Jan 6th, 2023.

Drew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Drew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Drew


  • Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $34 on, Thursday, November 3rd, 2022